K+S

Aging European Assets And Rising Costs Will Strain Margins

AnalystLowTarget

Not Invested

Community Contributor

Published

12 Jul 25

Updated

12 Dec 25

Views

n/a

AnalystLowTarget's Fair Value

n/a

10.4%

4.9%

10.4%

4.9%

You can edit this narrative until Dec 13 8:10 AM. Then, changes will post as Updates.

Author's Valuation

€852.8% overvalued

AnalystLowTarget Fair Value

Narrative

Updates1

Shared on 12 Dec 25

Fair value Decreased 5.88%

SDF: Persistent Price Target Cuts Will Signal Further Downside Risk Ahead

The analyst price target for K+S has been trimmed from roughly EUR 8.50 to EUR 8.00 as analysts factor in softer revenue growth expectations, despite slightly better margin forecasts and a lower future P E multiple. Analyst Commentary Recent Street research on K+S reflects a broadly cautious stance, with multiple bearish analysts trimming their price targets as they reassess the company outlook.

AnalystLowTarget Fair Value

€8

52.8% overvalued

Future estimation in

Growth p.a.

Decrease

Increase

Current revenue growth rate

1.10%

Chemicals revenue growth rate

0.58%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

5.78%

Calculation

€69.86m

Earnings '28

24.27x

PE Ratio '28

€1.70b

Market Cap '28

€1.70b

Market Cap '28

179.10m

No. shares '28

€9.47

Share Price '28

€9.47 Share Price '28

Discounted to 2025 @ 5.79% p.a.

€8.00

Fair Value '25